Brain Diseases  >>  buspirone/zolmitriptan (JM-010)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
buspirone/zolmitriptan (JM-010) / Bukwang Pharma
NCT02439203: Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Completed
2
30
RoW
JM-010, Placebo
Bukwang Pharmaceutical, Contera Pharma ApS
Parkinson's Disease, Levodopa Induced Dyskinesia (LID)
12/15
01/16

Download Options